Influence of seasonal climate differences on the pharmaceutical, hormone and personal care product removal efficiency of a drinking water treatment plant

Chemosphere

Volumn 93, Issue 9, 2013, Pages 2046-2054

  Azzouz, Abdelmonaim ^a   Ballesteros, Evaristo ^a  

^a UNIVERSITY OF JAÉN   (Spain)

Author keywords

Drinking water treatment plant; Hormones; Personal care product; Pharmaceuticals; Seasonal differences

Indexed keywords

AMIDES; AMMONIA; BIODEGRADATION; DRUG PRODUCTS; EFFICIENCY; ENDOCRINOLOGY; HORMONES; POTABLE WATER; POTASH; WATER SUPPLY; WATER TREATMENT PLANTS;

HIGH TEMPERATURE; PERSONAL CARE PRODUCTS; POTASSIUM PERMANGANATE; REMOVAL EFFICIENCIES; SEASONAL DIFFERENCES; SODIUM HYPOCHLORITES; SOLAR IRRADIANCES; WATER TREATMENT PROCESS;

WATER TREATMENT;

ACETYLSALICYLIC ACID; AMMONIA; CARBAMAZEPINE; CHLORAMPHENICOL; CLOFIBRIC ACID; DICLOFENAC; DRINKING WATER; ESTRADIOL; ESTRONE; ETHINYLESTRADIOL; FLORFENICOL; FLUNIXIN; HYPOCHLORITE SODIUM; IBUPROFEN; KETOPROFEN; MEFENAMIC ACID; METOPROLOL; NAPROXEN; NIFLUMIC ACID; PARACETAMOL; PERMANGANATE POTASSIUM; PHENYLBUTAZONE; PYRIMETHAMINE; THIAMPHENICOL; TRICLOSAN;

BIODEGRADATION; CONCENTRATION (COMPOSITION); DRINKING WATER; DRUG; HORMONE; IRRADIANCE; POLLUTANT REMOVAL; SEASONALITY; SOLAR RADIATION; WATER SUPPLY; WATER TREATMENT;

AQUEOUS SOLUTION; ARTICLE; AUTUMN; BIODEGRADATION; CHLORINATION; CLIMATE; CONCENTRATION (PARAMETERS); DEGRADATION; FILTRATION; HIGH TEMPERATURE; PRECIPITATION; SEASONAL VARIATION; SOLAR RADIATION; SPRING; SUMMER; TOTAL ORGANIC CARBON; TURBIDITY; ULTRAVIOLET IRRADIATION; WASTE COMPONENT REMOVAL; WATER QUALITY; WATER TEMPERATURE; WATER TREATMENT; WINTER;

SPAIN;

DRINKING WATER TREATMENT PLANT; HORMONES; PERSONAL CARE PRODUCT; PHARMACEUTICALS; SEASONAL DIFFERENCES;

CLIMATE; COSMETICS; ENVIRONMENTAL MONITORING; HORMONES; PHARMACEUTICAL PREPARATIONS; SEASONS; SPAIN; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL; WATER PURIFICATION;

EID: 84886388753     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.07.037     Document Type: Article

References (42)

1. Adams C., Wang Y., Loftin K., Meyer M. Removal of antibiotics from surface and distilled water in conventional water treatment processes. J. Environ. Eng. 2002, 128:253-260.
2. American Public Health Association Standard Methods for the Examination of Water and Wastewaters 1998, American Public Health Association, Washinnton, DC.
3. Azzouz A., Souhail B., Ballesteros E. Continuous solid-phase extraction and gas chromatography-mass spectrometry determination of pharmaceuticals and hormones in water samples. J. Chromatogr. A 2010, 1217:2956-2963.
4. Benotti M., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ. Sci. Technol. 2009, 43:597-603.
5. Boleda M.R., Galceran M.T., Ventura F. Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ. Pollut. 2011, 159:1584-1591.
6. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environ. Sci. Technol. 2010, 44:5619-5626.
7. Chamberlain E., Adams C. Oxidation of sulfonamides, macrolides, and carbadox with free chlorine and monochloramine. Water Res. 2006, 40:2517-2526.
8. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 2004, 38:947-954.
9. Daneshvar A., Svanfelt J., Kronberg L., Weyhenmeyer G.A. Winter accculation of acidic pharmaceuticals in a Swedish river. Environ. Sci. Pollut. Res. 2010, 17:908-916.
10. Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyer M.T., Zaugg S.D., Barber L.B., Thurman M.E. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II) Untreated drinking water sources. Sci. Total Environ. 2008, 402:201-216.
11. Gibs J., Stackelberg P.E., Furlong E.T., Meyer M., Zaugg S.D., Lippincott R.L. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time. Sci. Total Environ. 2007, 373:240-249.
12. Ginebreda A., Muñoz I., López de Alda M., Brix R., López-Doval J., Barceló D. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ. Int. 2010, 36:153-162.
13. Hu L., Martin H.M., Arce-Bulted O., Sugihara M.N., Keating K.A., Strathmann T.I. Oxidation of carbamazepine by Mn(VII) and Fe(VI): reaction kinetics and mechanism. Environ. Sci. Technol. 2009, 43:509-515.
14. Huber, M.M., Canonica, S., Park, G.Y., a von Gunten, U., 2003. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 37, 1016-1024.
15. Huber M.M., Göbel A., Joss A., Hermann N., Löffler D., Mcardell C.S., Ried A., Siegrist H., Ternes T.A., von Gunten U. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 2005, 39:4290-4299.
16. Jiang J., Pang S.Y., Ma J. Oxidation of triclosan by permanganate (Mn (VII)): importance of ligands and in situ formed manganese oxides. Environ. Sci. Technol. 2009, 43:8326-8331.
17. Jurado-Sánchez B., Ballesteros E., Gallego M. Occurrence of aromatic amines and N-nitrosamines in the different steps of a drinking water treatment plant. Water Res. 2012, 46:4543-4555.
18. Kumar A., Xagoraraki I. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. Sci. Total Environ. 2010, 408:5972-5989.
19. Kümmerer K. Antibiotics in the aquatic environment. A review. Part I. Chemosphere 2009, 75:417-434.
20. Kuster M., López de Alda M.J., Hernando M.D., Petrovic M., Martín-Alonso J., Barcelo D. Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). J. Hydrol. 2008, 358:112-123.
21. Lee Y., Escher B.I., von Gunten U. Efficient removal of estrogenic activity during oxidative treatment of waters containing steroid estrogens. Environ. Sci. Technol. 2008, 42:6333-6339.
22. Loraine G., Pettigrove M.E. Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in Southern California. Environ. Sci. Technol. 2006, 40:687-695.
23. Ma G., Graham N., Li G. Effect of permanganate preoxidation in enhancing the coagulation of surface water-laboratory case studies. J. Water Supply Res. Technol. - Aqua 1997, 46:1-10.
24. Moldovan Z. Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere 2006, 64:1808-1817.
25. Pinkston K.E., Sedlak D.L. Transformation of aromatic ether- and amine-containing pharmaceuticals during chlorine disinfection. Environ. Sci. Technol. 2004, 38:4019-4025.
26. Santos J.L., Aparicio I., Callejon M., Alonso E. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). J. Hazad. Mater. 2009, 164:1509-1516.
27. Snyder S.A., Wert E.C., Rexing D.J., Zegers R.E., Drury D.D. Ozone oxidation of endocrine disruptors and pharmaceuticals in surface water and wastewater. Ozone: Sci. Eng. 2006, 28:445-460.
28. Snyder S.A., Wert E.C., Lei H., Westerhoff P., Yoon Y. Removal of EDCs and pharmaceuticals in drinking and reuse treatment process 2007, American Water Works Association, Denver.
29. Sorensen L.K., Elbaek T.H. Simultaneous determination of trimethoprim, sufadiazine, florfenicol and oxolinic acid in surface water by liquid chromatography tandem mass spectrometry. Chromatographia 2004, 60:287-291.
30. Soufan M., Deborde M., Legube B. Aqueous chlorination of diclofenac: kinetic study and transformation products identification. Water Res. 2012, 46:3377-3386.
31. Stackelberg P.E., Furlong E.T., Meyer M.T., Zaugg S.D., Henderson A.K., Reissman D.B. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water treatment plant. Sci. Total Environ. 2004, 329:99-113.
32. Stackelberg P.E., Gibs J., Furlong E.T., Meyer M.T., Zaugg S.D., Lippincott R.L. Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci. Total Environ. 2007, 377:255-272.
33. Ternes T.A., Meisenheimer M., Mcdowell D., Sacher F., Brauch H.J., Haist-Gulde B., Preuss G., Wilme U., Zulei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 2002, 36:3855-3863.
34. Tixier C., Singer H.P., Oellers S., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 2003, 37:1061-1068.
35. Veach A.M., Bernot M.J. Temporal variation of pharmaceuticals in an urban and agriculturally influent stream. Sci. Total Environ. 2011, 409:4553-4563.
36. Vieno N.M., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant in the recipient water. Environ. Sci. Technol. 2005, 39:8220-8226.
37. Waldemer R.H., Tratnyek P.G. Kinetics of contaminant degradation by permanganate. Environ. Sci. Technol. 2006, 40:1055-1061.
38. Wang C., Shi H., Adams C.D., Gamagedara S., Stayton I., Timmons T., Ma Y. Investigation of pharmaceuticals in Missouri natural and drinking water using high performance liquid chromatography-tandem mass spectrometry. Water Res. 2011, 45:1818-1828.
39. Westerhoff R., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005, 39:6649-6663.
40. Wu Q., Shi H., Adams C.D., Timmons T., Ma Y. Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan. Sci. Total Environ. 2012, 439:18-25.
41. Ying, G.G., 2007. Analysis of endrocrine disrupting chemicals and pharmaceuticals and personal care products in water. In: Nollet, L.M.L. (Ed.), Handbook of Water Analysis. Boca Raton, CRC Press, Taylor & Francis, Group, pp. 693-727.
42. Zwiener C., Frimmel F.H. Oxidative treatment of pharmaceuticals in water. Water Res. 2000, 34:1881-1885.